BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 25052913)

  • 1. Does quantitative EMG differ myotonic dystrophy type 2 and type 1?
    Szmidt-Salkowska E; Gawel M; Lusakowska A; Nojszewska M; Lipowska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
    J Electromyogr Kinesiol; 2014 Oct; 24(5):755-61. PubMed ID: 25052913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
    Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
    Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle involvement in myotonic dystrophy type 2. A comparative muscle ultrasound study.
    Tieleman AA; Vinke A; van Alfen N; van Dijk JP; Pillen S; van Engelen BG
    Neuromuscul Disord; 2012 Jun; 22(6):492-9. PubMed ID: 22414627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of short exercise and short exercise with cooling tests in the diagnosis of myotonic dystrophies (DM1 and DM2).
    Gawel M; Szmidt-Salkowska E; Lusakowska A; Nojszewska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
    Muscle Nerve; 2014 Feb; 49(2):277-83. PubMed ID: 23716346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electrophysiological features of patients with myotonic dystrophy type 1].
    Li M; Wang ZJ; Cui F; Yang F; Chen ZH; Ling L; Huang XS
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(5):345-7. PubMed ID: 23660205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated size index valid for both neurogenic and myogenic changes.
    Sonoo M; Ogawa G; Hokkoku K; Stålberg E
    Muscle Nerve; 2020 Dec; 62(6):735-741. PubMed ID: 32940356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies.
    Peric S; Maksimovic R; Banko B; Durdic M; Bjelica B; Bozovic I; Balcik Y; Pesovic J; Savic-Pavicevic D; Rakocevic-Stojanovic V
    J Neurol; 2017 Sep; 264(9):1899-1908. PubMed ID: 28756605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
    Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
    Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absent, unrecognized, and minimal myotonic discharges in myotonic dystrophy type 2.
    Young NP; Daube JR; Sorenson EJ; Milone M
    Muscle Nerve; 2010 Jun; 41(6):758-62. PubMed ID: 20513102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2 : a whole body highfield MRI study.
    Kornblum C; Lutterbey G; Bogdanow M; Kesper K; Schild H; Schröder R; Wattjes MP
    J Neurol; 2006 Jun; 253(6):753-61. PubMed ID: 16511650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body composition analysis in patients with myotonic dystrophy types 1 and 2.
    Peric S; Bozovic I; Nisic T; Banovic M; Vujnic M; Svabic T; Pesovic J; Brankovic M; Basta I; Jankovic M; Savic-Pavicevic D; Rakocevic-Stojanovic V
    Neurol Sci; 2019 May; 40(5):1035-1040. PubMed ID: 30790082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor unit reorganization in progressive muscular dystrophies and congenital myopathies.
    Szmidt-Sałkowska E; Gaweł M; Lipowska M
    Neurol Neurochir Pol; 2015; 49(4):223-8. PubMed ID: 26188938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
    Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
    Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes.
    Sansone VA; Brigonzi E; Schoser B; Villani S; Gaeta M; De Ambroggi G; Bandera F; De Ambroggi L; Meola G
    Int J Cardiol; 2013 Sep; 168(2):1147-53. PubMed ID: 23266299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splicing biomarkers of disease severity in myotonic dystrophy.
    Nakamori M; Sobczak K; Puwanant A; Welle S; Eichinger K; Pandya S; Dekdebrun J; Heatwole CR; McDermott MP; Chen T; Cline M; Tawil R; Osborne RJ; Wheeler TM; Swanson MS; Moxley RT; Thornton CA
    Ann Neurol; 2013 Dec; 74(6):862-72. PubMed ID: 23929620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical motor unit potentials in Emery-Dreifuss muscular dystrophy (EDMD).
    Rowińska-Marcińska K; Szmidt-Sałkowska E; Fidziańska A; Zalewska E; Dorobek M; Karwańska A; Hausmanowa-Petrusewicz I
    Clin Neurophysiol; 2005 Nov; 116(11):2520-7. PubMed ID: 16214403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.
    Suominen T; Bachinski LL; Auvinen S; Hackman P; Baggerly KA; Angelini C; Peltonen L; Krahe R; Udd B
    Eur J Hum Genet; 2011 Jul; 19(7):776-82. PubMed ID: 21364698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
    Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
    Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.